The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
出版年份 2019 全文链接
标题
The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume -, Issue -, Pages -
出版商
Oxford University Press (OUP)
发表日期
2019-01-26
DOI
10.1093/jnci/djz011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review
- (2018) Federica Duregon et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
- (2018) Katherine Stockstill et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trial designs for chemotherapy-induced peripheral neuropathy prevention
- (2018) Jennifer S. Gewandter et al. NEUROLOGY
- Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics
- (2017) Andreas A. Argyriou et al. Nature Reviews Neurology
- Chemotherapy-induced peripheral neuropathy clinical trials
- (2017) Jennifer S. Gewandter et al. NEUROLOGY
- Paclitaxel Reduces Axonal Bclw to Initiate IP 3 R1-Dependent Axon Degeneration
- (2017) Sarah E. Pease-Raissi et al. NEURON
- Eight-week, multimodal exercise counteracts a progress of chemotherapy-induced peripheral neuropathy and improves balance and strength in metastasized colorectal cancer patients: a randomized controlled trial
- (2017) Philipp Zimmer et al. SUPPORTIVE CARE IN CANCER
- Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial
- (2017) Ian R. Kleckner et al. SUPPORTIVE CARE IN CANCER
- A Systematic Review of Treatment of Painful Diabetic Neuropathy by Pain Phenotype versus Treatment Based on Medical Comorbidities
- (2017) Luiz Clemente Rolim et al. Frontiers in Neurology
- Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy
- (2016) D. L. Hertz et al. CLINICAL CANCER RESEARCH
- The emerging role of FTY720 (Fingolimod) in cancer treatment
- (2016) Christopher White et al. Oncotarget
- Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity
- (2016) Jing Zhu et al. Scientific Reports
- Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
- (2015) Deirdre R. Pachman et al. JOURNAL OF CLINICAL ONCOLOGY
- National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons
- (2015) Neil Majithia et al. SUPPORTIVE CARE IN CANCER
- The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
- (2015) N C Hait et al. Oncogenesis
- Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy
- (2014) F. Streckmann et al. ANNALS OF ONCOLOGY
- Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy
- (2014) K S Courneya et al. BRITISH JOURNAL OF CANCER
- The Development and Maintenance of Paclitaxel-induced Neuropathic Pain Require Activation of the Sphingosine 1-Phosphate Receptor Subtype 1
- (2014) Kali Janes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
- (2014) Marta Seretny et al. PAIN
- The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: A randomised, double-blind, placebo-controlled phenotype-stratified study
- (2014) Dyveke T. Demant et al. PAIN
- Ethoxyquin prevents chemotherapy-induced neurotoxicity via Hsp90 modulation
- (2013) Jing Zhu et al. ANNALS OF NEUROLOGY
- Second generation S1P pathway modulators: Research strategies and clinical developments
- (2013) Marc Bigaud et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production
- (2013) Lei Gong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain
- (2013) Daniela Salvemini et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
- (2013) Yaqin Han et al. Frontiers in Pharmacology
- Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401
- (2012) William Kevin Kelly et al. JOURNAL OF CLINICAL ONCOLOGY
- Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
- (2012) Christian A. von Hehn et al. NEURON
- Reliability and Validity of Gait Analysis by Android-Based Smartphone
- (2012) Shu Nishiguchi et al. Telemedicine and e-Health
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- BCL-2 family antagonists for cancer therapy
- (2008) Guillaume Lessene et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More